Hoth Therapeutics Retains Venable LLP to Expand Its Patent Portfolio
NEW YORK, Feb. 29, 2024 /PRNewswire/ — Hoth Therapeutics, Inc. (NASDAQ:HOTH), a patient-focused biopharmaceutical company, today announced that it will continue its work with Venable, LLP to develop and protect its intellectual property. Venable is an American Lawyer Global 100 law firm that serves as primary counsel to a worldwide clientele of large and mid-sized organizations and nonprofits and individuals. With more than 900 professionals across the country, the firm strategically advances its clients’ objectives in the United States and around the globe. Venable advises clients on a broad range of topics, including the full range of intellectual property disciplines.